Compared with the full-length human antibody against bFGF, the ds-Diabody against bFGF showed a stronger inhibitory effect on the growth of tumor, possibly because the ds-Diabody agasint bFGF has a stronger penetration with low molecular weight. The gene discussed is FGF2; the disease is neoplasm.